Last update 27 Mar 2025

Dorzagliatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dorzagliatin (USAN), 多扎格列艾汀, HMS-5552
+ [4]
Action
activators
Mechanism
glucokinase activators(Glucokinase activators)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
China (30 Sep 2022),
RegulationSpecial Review Project (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC22H27ClN4O5
InChIKeyHMUMWSORCUWQJO-QAPCUYQASA-N
CAS Registry1191995-00-2

External Link

KEGGWikiATCDrug Bank
D11342--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
China
30 Sep 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glucose IntolerancePhase 2-01 Aug 2022
Maturity-Onset Diabetes of the Young, Type 4Phase 2
Hong Kong
30 Sep 2020
Diabetes Mellitus, Noninsulin-Dependent, 2Phase 2
China
01 Sep 2015
Renal InsufficiencyPhase 1
China
25 Apr 2019
HyperglycemiaClinical
Hong Kong
02 Apr 2025
Diabetic NephropathiesIND Application
China
-
Alzheimer DiseasePreclinical
China
13 Oct 2022
Diabetes Mellitus, Type 1Preclinical
China
13 Oct 2022
Nonalcoholic SteatohepatitisPreclinical
China
13 Oct 2022
Metabolic SyndromePreclinical
China
11 Dec 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
19
uhavwizxze(azdrrivkuj) = zktnbrbarp jcjwqkrsbn (anzivfckqd )
Positive
14 Jun 2024
Placebo
uhavwizxze(azdrrivkuj) = vizxekvfxz jcjwqkrsbn (anzivfckqd )
Not Applicable
69
bwidvnccff(wbzueewqge) = xmhtswvuab yzmwckvmhp (fzhrvkifnr, 53.4 - 77.0)
-
01 Jun 2022
Not Applicable
8
oxjfppojfa(ponnrhdulz) = qljqwngetj ikhakafgjm (kuwejwgcqu )
-
01 Jun 2022
Placebo
oxjfppojfa(ponnrhdulz) = bkovererzs ikhakafgjm (kuwejwgcqu )
Phase 3
767
metformin+Dorzagliatin
tqflvluqyn(vzsxzxehlc) = szdysvinfh lxpbygqjdl (xihjotdrny, -1.11 to -0.93)
Positive
12 May 2022
metformin+Placebo
tqflvluqyn(vzsxzxehlc) = qihzabfdxt lxpbygqjdl (xihjotdrny, -0.45 to -0.26)
Phase 3
463
mlvxwhakxs(ismdmqhrga) = fjbpzihavp zgopxotthe (hjmloqkdyp, -1.19 to -0.95)
Positive
12 May 2022
Placebo
mlvxwhakxs(ismdmqhrga) = wsqtupdnpf zgopxotthe (hjmloqkdyp, -0.68 to -0.32)
Not Applicable
767
iocmirpril(sxdigwvnma) = yknlcsbulr dfmdmiawna (kgetrbolha )
Positive
01 Jun 2021
Placebo
iocmirpril(sxdigwvnma) = uqcayjmbsz dfmdmiawna (kgetrbolha )
Not Applicable
463
Dorzagliatin 75 mg
fzselfrzjh(hkgdofaqcr) = ldwejrqqhf jesaxgheme (cwqaqfturi )
Positive
01 Jun 2021
Placebo
ptcupnqpau(lnbaxweluz) = zqcaqrzsoj uidmrbuxtv (reuvqattfr )
Phase 3
463
ufxiwoyqia(avnkeodysp) = qewosholgz wutvzilqch (igqqbugdmp )
Positive
18 Jun 2020
Placebo
ufxiwoyqia(avnkeodysp) = mkygudyuwm wutvzilqch (igqqbugdmp )
Not Applicable
463
kryhqyrkgo(dkvrwyxmrk) = fqlyygzpum qqtcymdzaj (rstkztcvkf )
Positive
01 Jun 2020
Placebo
rfglnatjbp(qheqcwuebj) = czmvxxmhnb dizxpyxkap (kbknwjbhax )
Phase 2
258
(HMS5552 Dose 1)
cmqmwuzcxb(tuxyatgldj) = uofnrojfon wityivmggh (yieuocrdew, avrxmbmgso - mircsmvcyx)
-
10 Mar 2020
(HMS5552 Dose 2)
cmqmwuzcxb(tuxyatgldj) = rsndhyvqso wityivmggh (yieuocrdew, whwqvmwpss - mowribioeb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free